(5Z)-3-Methyl-5-[(naphthalen-1-yl)methylidene]-1,3-thiazolidine-2,4-dione

Catalog No. :
ACNCSI261
CAS No. :
866137-01-1
Molecular Formula :
C15H11NO2S
Molecular Weight :
269.33

IUPAC Name:(Z)-3-methyl-5-(naphthalen-1-ylmethylene)thiazolidine-2,4-dione

(5Z)-3-Methyl-5-[(naphthalen-1-yl)methylidene]-1,3-thiazolidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5Z)-3-Methyl-5-[(naphthalen-1-yl)methylidene]-1,3-thiazolidine-2,4-dione
IUPAC Name(Z)-3-methyl-5-(naphthalen-1-ylmethylene)thiazolidine-2,4-dione
MDL No.MFCD03305807
Molecular FormulaC15H11NO2S
Molecular Weight269.33
SMILESO=C(N(C)C/1=O)SC1=C/C2=C3C=CC=CC3=CC=C2
InChI KeyXMECQSFJGDKXMO-LCYFTJDESA-N
Synonym3-METHYL-5-[(Z)-1-NAPHTHYLMETHYLIDENE]-1,3-THIAZOLANE-2,4-DIONE;(5Z)-3-methyl-5-[(naphthalen-1-yl)methylidene]-1,3-thiazolidine-2,4-dione;2,4-Thiazolidinedione, 3-methyl-5-(1-naphthalenylmethylene)-
CAS No.866137-01-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNCSI261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDNVB185 route compound structure diagram
    ACDNVB18516312-21-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNCSI261 route product structure diagram
    ACNCSI261866137-01-1
Inquiry

2. ACNCSI261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNCSI261 route product structure diagram
    ACNCSI261866137-01-1
Inquiry

Comments (0)